SkinHealth Systems financials
$0.6500−2.23%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72.1M | $64.9M | $82.4M | $70.7M | $78.2M | $69.6M | $83.5M | $78.8M | $90.6M | $81.4M | $96.8M | $97.4M |
| Gross profit | $49.3M | $44.4M | $53.0M | $45.6M | $49.1M | $48.6M | $52.3M | $40.6M | $40.9M | $48.4M | $45.7M | -$12.6M |
| Gross margin | 68.4% | 68.5% | 64.4% | 64.6% | 62.8% | 69.8% | 62.7% | 51.6% | 45.2% | 59.4% | 47.2% | −12.9% |
| Operating income | $3.6M | -$1.8M | $162.0K | -$6.2M | -$2.7M | -$12.0M | -$7.2M | -$21.5M | -$22.1M | -$17.0M | -$18.4M | -$82.1M |
| Net income | -$2.7M | -$6.6M | -$8.1M | -$11.0M | $19.7M | -$10.1M | -$10.3M | -$18.3M | $202.0K | -$679.0K | -$9.4M | -$73.8M |
| Net margin | −3.7% | −10.2% | −9.8% | −15.6% | 25.2% | −14.5% | −12.4% | −23.2% | 0.2% | −0.8% | −9.7% | −75.8% |
| Diluted EPS | $-0.02 | $-0.05 | $-0.05 | $-0.09 | $0.03 | $-0.08 | $-0.06 | $-0.15 | $-0.10 | $-0.10 | $-0.07 | $-0.56 |
| EBITDA | $8.8M | $3.5M | $5.5M | $2.2M | $2.7M | -$5.9M | -$598.0K | -$12.0M | -$13.2M | -$8.3M | -$18.4M | -$74.1M |
| Operating cash flow | $2.7M | -$5.6M | $15.2M | $9.6M | $9.6M | $3.0M | $16.5M | $10.3M | $6.2M | -$16.9M | -$5.2M | $18.0M |
| Free cash flow | $2.2M | -$5.8M | $15.1M | $9.6M | $9.6M | $3.0M | $16.4M | $10.3M | $5.9M | -$17.2M | -$5.2M | $17.8M |
| Diluted shares | 129.6M | 131.4M | 150.9M | 126.9M | 140.3M | 125.1M | 159.5M | 124.1M | 141.9M | 144.5M | 128.7M | 132.9M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $206.1M | $204.4M | $232.7M | $219.4M | $212.0M | $373.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $345.2M | $344.2M | $364.4M | $363.4M | $363.1M | $553.0M |
| Total assets | $486.6M | $473.2M | $499.8M | $503.6M | $507.6M | $673.8M |
| Total liabilities | $431.0M | $418.0M | $438.7M | $438.0M | $433.6M | $627.8M |
| Shareholders' equity | $55.6M | $55.2M | $61.1M | $65.7M | $74.0M | $46.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology